Asahi Life Asset Management’s Royalty Pharma RPRX Stock Holding History

Asahi Life Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$388K	Sell	6,926 -640	-8%	-$33.3K	0.22%	119
2026 Q1	$363K	Sell	7,566 -1,909	-20%	-$83.6K	0.23%	91
2025 Q4	$366K	Buy	+9,475	New	+$361K	0.2%	130
2024 Q4	–	Sell	-11,110	Closed	-$314K	–	214
2024 Q3	$314K	Buy	11,110 +280	+3%	+$7.76K	0.19%	146
2024 Q2	$286K	Buy	+10,830	New	+$300K	0.2%	137
2024 Q1	–	Sell	-11,650	Closed	-$327K	–	204
2023 Q4	$327K	Buy	+11,650	New	+$320K	0.18%	127

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Asahi Life Asset Management's RPRX Position: Q2 2026 in Review

Asahi Life Asset Management reduced its Royalty Pharma (RPRX) stake by 8.5% in Q2 2026, selling an estimated $33.3K and leaving 6,926 shares worth $388K. The position accounts for 0.22% of the portfolio, ranked #119.

Asahi Life Asset Management first reported a position in RPRX in Q4 2023 and has held it in 6 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Asahi Life Asset Management held 6,926 shares of Royalty Pharma worth $388K as of Q2 2026.
Asahi Life Asset Management sold 640 Royalty Pharma shares in Q2 2026, an estimated $33.3K.
Royalty Pharma made up 0.22% of Asahi Life Asset Management's portfolio in Q2 2026, its #119 holding.
Asahi Life Asset Management first reported a position in Royalty Pharma in Q4 2023 and has held it in 6 quarters since.
645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Asahi Life Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.